Review of Osteopenia
Kathy KL Tsim 詹觀蘭
HK Pract 2020;42:62-69
Summary
In a world with an increasing aged population,
osteoporosis has become a recognised global health
problem with its substantial bone-associated morbidities,
mortality and health-care costs. The stage before
osteoporosis occurs is called osteopenia. Having
osteopenia does not necessarily proceed to osteoporosis.
However, steps can be taken to improve a person’s bone
health and to reduce their osteoporotic risk.
This article will share with the readers the current
knowledge , controversies and management of
osteopenia, osteoporosis and osteosarcopenia.
摘要
伴隨人口老化,骨質疏鬆引發大量相關骨病的發病率,以致增加了死亡率和醫療成本,骨質疏鬆已經被公認為全球的健康問題。骨質疏鬆的前期為缺乏骨質,然而通過治療,改善骨質健康,可以減低發展為骨質疏鬆的危險。本文作者與讀者分享了,有關骨質缺乏和骨質疏鬆和骨肌肉減少症候群(osteosarcopenia)的討論意見,和最新知識及治療方法。
Introduction
Losing bone density is a normal part of ageing and
is person specific. The stage preceding osteoporosis is
known as osteopenia. This condition occurs because the
osteoid synthesis is not sufficient to overcome osteoid
lysis. Osteopenia is having a lower bone density than
the average for the patient’s age group, but not low
enough to be classified as osteoporosis.
The UK Royal Osteoporosis Society states that
having a low bone density can increase a person’s
fracture risk, but is not necessarily an imminent event.
Osteopenia is one of many risk factors for sustaining
fractures. Whether actual medical treatment is deemed
necessary depends on the outcome of a person’s
fracture risk assessment. 1
Impact of osteopenia and osteoporosis in
society
According to a 2016 systematic review and meta-analysis, it was found that the pooled
prevalence of
osteoporosis in people aged 50 years and older in
China was more than twice the pooled prevalence
identified in 2006. 2
This figure has increased over the
past 12 years, affecting more than one-third of the
people aged 50 years and older. No specific prevalence
data is currently available for Hong Kong. However,
epidemiological studies has shown that the incidence
of hip fracture has increased by 300% from 1960s to
1990s. Fortunately this has since stabilised from 2001-
2006. 3
Despite the stabilisation of hip fracture rates,
fractures remain a major burden on health services and
society. The prevalence of vertebral fractures in men
and women between the ages of 70-79 are comparable
to those in American Caucasians.
Osteoporosis is not officially documented as a
national health priority in Hong Kong. 4Nevertheless,
osteoporosis is a major and increasingly important
public health issue in our locality. Although the
incidence of age-adjusted hip fractures seems to be
decreasing over time when compared to Caucasians,
Hong Kong men and women still have a high prevalence
of osteoporosis and a lower Bone Mineral Density
(BMD) (osteopenia) rate. Prevention and control
measures have become important in a society which is
growing older and the care burden from bone fractures
are forever increasing.
Recently, there has been the recognition of
osteosarcopenia, a syndrome seen in frail, elderly
patients as having a higher risk of falls, fractures,
disability and frailty. This new syndrome, consists
of a combination low Bone Mineral Density (BMD
T-score <–1 standard deviation) and sarcopenia.
Sarcopenia is defined as a “syndrome characterised
by progressive and generalised loss of skeletal muscle
mass and strength, with a risk of adverse outcomes
such as physical disability, poor quality of life and
high mortality” 5
which can be detected with the use
of dual-energy X-ray absorptiometry (DEXA) or
bioelectrical impedance analysis (BIA). In other words,
osteosarcopenia has been defined as the presence of
sarcopenia and osteopenia or osteoporosis.5
Interestingly studies of patients with type-1
diabetes mellitus have demonstrated an association
between BMD and microvascular complications. 6,7,8
Most studies reporting an increased prevalence of
fractures in these patients despite an apparently
increased bone mineral density. Some advocate that
fragility / low-impact fractures may be a “neglected”
complication of diabetes.
Detection of osteopenia
Unlike osteoporosis (even in the absence of
fractures) which can result in chronic pain affecting a
person’s daily activities, osteopenia is asymptomatic. 2
This means that osteopenia can go undetected for years
before bone loss is so severe that osteoporosis develops.
When osteopenia does cause symptoms, it may
result in localised bone pain and /or low-impact
fractures. Low-impact fractures can often be the result
of falls from one’s own standing height or lower.
They can happen during normal daily activities, e.g.
from getting out of a chair or stepping off of a curb.
Interestingly, sometimes bone fractures can even occur
without noticeable pain.
Osteopenia may be suspected by findings on plain
film X-ray of increased bone radiolucency which can be
seen as a decreased cortical thickness and loss of bony
trabeculae. However, the standard test for measuring
the density of bone and detecting osteopenia is a bone
density test, either via a CT scan of the lumbar spine
(quantitative computed tomography or QCT) 9,10 or, more
commonly, by DEXA (dual energy X-ray absorption)
bone density test. Ultrasound of the bones of the
heel, leg, kneecap, or other areas are sometimes used
commercially.
The World Health Organisation (WHO) has
established DEXA as the best densitometric technique
for assessing BMD ( Bone mineral density ) in
postmenopausal women and based the definitions of
osteopenia and osteoporosis on its results. It is the
gold standard imaging technique for the assessment
of BMD. It not only allows for the accurate diagnosis
of osteoporosis, fracture prediction, but also as a
monitoring tool for patients undergoing treatment.
DEXA scanner uses beams of very low-energy radiation
to determine the density of bone. The amount of
radiation is low: about one-tenth of a chest X-ray.
There are significant differences in the
performance of different techniques to predict fractures
at different skeletal sites. The bone density test
provides a numerical rating of the density of the bones
measured. Bones that are often tested in this manner
include the lumbar spine, the femur bone of the hip,
and the forearm bone. DEXA scores are reported as
"T-scores" and "Z-scores". 11
"T-scores" and "Z-scores"
The T-score is a comparison of a person's bone
density with that of a healthy 30-year-old of the same
sex. The Z-score is a comparison of a person's bone
density with that of an average person of the same age
and sex. Lower scores (more negative) mean lower bone
density.
- T-scores greater than -1.0 SD (Standard
Deviation) are considered normal and indicate
healthy bone.
- T-scores between -1.0 SD and -2.5 SD indicate
osteopenia (meaning below-normal bone
density without full osteoporosis.)
- T-scores lower than -2.5 SD indicate
osteoporosis.
Multiplying the T-score by 10% gives a rough
estimate of how much bone density has been lost.
Although the reference standard for the description of
osteoporosis is BMD at the femoral neck, other central
sites (e.g. lumbar spine, total hip) can be used for
diagnosis in clinical practice.
T-scores should be reserved for diagnostic use
in postmenopausal women and men aged 50 years or
more. 12 With other measurement techniques, and other
populations, values should be expressed as Z-scores,
other units of measurement or preferably in units of
fracture risk. In premenopausal women, a low Z-score
(below -2.0) indicates that bone density is lower than
expected and should trigger a search for an underlying
cause.
Re-screening, for women with normal bone density
or mild osteopenia, is advocated to be at an interval
of 15 years and 5 years for women with moderate
osteopenia, and yearly for women with advanced
osteopenia. 13 It was found that 10% of women with
moderate osteopenia at baseline developed osteoporosis
within 5 years. For those with advanced osteopenia at
the start, about 10% had developed osteoporosis within
a year, suggesting more aggressive yearly screening to
be more appropriate. This is assumed that no other risk
factors has arisen since their last screening.
Meanwhile, a prediction tool, the Osteoporosis
Preclinical Assessment Tool (OPAT), has been
developed to assess the osteopenia risk of women aged
40-55 years by a group of Taiwanese researchers in
2010. This tool collected the age, menopausal status,
weight, and serum total Alkaline phosphatase (ALP)
level of patients in order to predict their osteopenia
risk. It acts as a simple and accurate prescreening tool
for identifying premenopausal and early postmenopausal
women without the need for bone mineral density
values unlike the most widely used FRAX@ on-line
questionnaire. 14 Just as the authors has indicated more
validation of this tool is needed; but hopefully this will
be available as a tool that physicians can access soon in
the near future.
What are causes and risk factors for
osteopenia?
Normal bone development with achievement of
peak bone mass is influenced by several factors: i.e.
genetics 15,16,17, nutritional status, hormones, exercise18,
and other physical factors. Hence possible risk factors
for osteopenia include the following 18:
- Family history of osteoporosis
- Inactivity
- Older age group
- Smoking
- Regular alcohol intake
- Asian / Caucasian descent
- Thin body habitus
- Corticosteroid (prednisone or prednisolone)
usage
- Low estrogen in women
- Low testosterone in men
- Malabsorption conditions (such as celiac disease)
- Rheumatoid arthritis
It is important to differentiate other causes
of osteopenia, for example, osteomalacia, primary
hyperparathyroidism, and malignant diseases such as
myeloma, since these bone diseases have a different
natural history, pathophysiology, and treatment.
What can patients with osteopenia do to improve
their bone health?
As family physicians there are some simple but
very important things that we can advise our patients
with osteopenia to ensure better bone health. The
following practices should be encouraged 18:
- Exercise: weight-bearing and resistance
exercises at least 3 times a week . (see
Appendix)
- Calcium: 3 daily servings of dairy foods, or
other calcium rich foods.
- Vitamin D: get-out and about in the sun, for
short periods at a time, on most days.
- Reduce and stop smoking.
- Reduce alcohol intake to a minimum.
(A) Exercise
Exercise is important to prevent osteopenia
and henceforth osteoporosis. Physical activities
during childhood and adolescence increase bone
density and strength. Children who exercise
are likely to reach a higher peak bone density
(maximum strength and solidness). Peak bone
density is reached during mid- to late- 20s. 14 People
who reach a higher bone density are less likely to
develop osteopenia, and hence osteoporosis.
Physical activity throughout life is also
important in maintaining adequate bone mass
and bone health. Even in older adults, strength
training has a significant positive influence on
BMD with osteoporosis or osteopenia. 19 Even a
general-purpose exercise program with emphasis
on bone density has a positive impact in osteopenic
women. 20 Exercise can improve not only a person’s
strength and endurance, but it can also reduce
back pain, and improve lipid levels. However,
it is recommended not to rely on exercise alone
but rather to combine strength training, diet and
supplements to ensure good bone health.
Types of exercises for bone health 21,22
There are two types of important exercises
that are important for building and maintaining
bone density : weight-bearing and muscle-
strengthening exercises.
-
Weight-bearing exercises
These exercises include activities that
make one move against gravity while staying
upright. Weight-bearing exercises can be high-impact or low-impact.
High-impact weight-bearing exercises include:
- Dancing
- Doing high-impact aerobics
- Hiking
- Jogging / Running
- Rope jumping
- Climbing up and down stairs
- Tennis
Low-impact weight-bearing exercises are a
safe alternative if a patient cannot do high-impact exercises. Examples of
low-impact
weight-bearing exercises are:
- Using elliptical training machines
- Doing low-impact aerobics
- Using stair-step machines
- Fast walking on a treadmill or outside
-
Muscle-strengthening exercises
These exercises are also known as resistance
exercises and include:
- Lifting weights
- Using elastic exercise bands
- Using weight machines
- Lifting your own body weight
- Functional movements, such as standing
and rising up on your toes
General rules
- Exercise must be regular (at least 3 times per
week)
- Exercise should progress over time (amount
of weight used, degree of exercise difficulty,
height of jumps must increase or vary over
time to challenge bones and muscles)
- Exercise routines should be varied (variety in
routines is better than repetition)
- Exercise should be performed in short ,
intensive bursts
Note:
- Leisure walking on its own is not recommended
as an adequate strategy for bone health,
although it has benefits for general health
and fitness. Swimming and cycling are also
considered low impact sports that are not
specifically beneficial for bone health.
- Yoga and Pilates can also improve strength,
balance and flexibility if patient are supervised
by a trained therapist in order to prevent
unnecessary stress to already fragile bones.
(B) Calcium
The US Food and Nutrition Board (FNB) has
established Recommended Dietary Allowances
(RDAs) which are the reference for average daily
level of intake sufficient to meet the nutrient
requirements of nearly all (97%-98%) healthy
individuals for the amounts of calcium required
for bone health. They are listed in Table 1 in
milligrams (mg) per day.
Recommended intake as seen is different in the US as
compare to our locality.
Reference: The Chinese Dietary reference intake (2013)
The Food and Agriculture Organisation
of the United Nations (FAO) and World Health
Organisation ( WHO ) recommendations for
calcium intake is between 1000 and 1300 mg/
day and nearly all Asian countries fall far below
this general recommended level. The median
dietary calcium intake for the adult Asian
population is approximately 450 mg/day, with a
potential detrimental impact on bone health in
the region. 25,26,27 This is further supported by data
from the 2015 China Nutritional Transition Cohort
Study (CNTS) showing that calcium deficiency is
a very common nutritional problem in the world
but especially so in China. 27
Since January 2010 the US Food and Drug
Administration (FDA) statement on calcium,
vitamin D and bone health is that adequate calcium
and vitamin D should be part of a healthy diet,
along with physical activity with the possible
beneficial effect of reducing osteoporosis risk in
later life.
Calcium supplementation
The two main forms of calcium in supplements
are carbonate and citrate. Calcium carbonate is
more commonly available and is both inexpensive
and convenient. Due to its dependence on stomach
acid for absorption, calcium carbonate is absorbed
most efficiently when taken with food, whereas
calcium citrate is absorbed equally well when taken
with or without food. 23
Calcium citrate is useful for people with
achlorhydria, inflammatory bowel disease, or
absorption disorders. Other calcium forms in
supplements or fortified foods include gluconate,
lactate, and phosphate.
Calcium supplements contain varying amounts
of elemental calcium. For example, calcium
carbonate is 40% calcium by weight, whereas
calcium citrate is 21% calcium. Fortunately,
elemental calcium is listed in the bottle’s
supplement facts panel, so consumers do not need
to calculate.
Foods that affect Calcium absorption
- Caffeine intake: this stimulant in coffee and
tea can increase calcium excretion and hence
reduce absorption. One cup of regular brewed
coffee causes a loss of 2-3 mg of calcium.
Moderate caffeine consumption (1 cup of
coffee or 2 cups of tea per day) in young
women has no negative effects on bone.
- Alcohol intake: alcohol intake can affect
calcium status by reducing its absorption and
by inhibiting enzymes in the liver that help
convert vitamin D to its active form. However,
the amount of alcohol required to affect
calcium status and whether moderate alcohol
consumption is helpful or harmful to bone is
unknown
Absorption is highest in doses ≤500 mg per
dosing. So it is best to split a 1,000 mg/day of
calcium supplement tablet into 500 mg at two
separate times during the day.
(C) Vitamin D
Local studies have found that vitamin D
deficiency is highly prevalent even in healthy
young adults. 28 This is a surprise finding in such
an affluent city like Hong Kong where there is
no lack of available sunshine or food. For most
people, 5 to 15 minutes of casual sun exposure
of the hands, face and arms 2 to 3 times a week
during the summer months is sufficient to keep the
vitamin D level high. People with darker skin need
a longer sun exposure time. 29
It has been reported that in Hong Kong, the
means of serum 25-hydroxy vitamin D (calcifediol)
levels in different age groups were lower when
compared with similar age groups from Japan,
Thailand, Taiwan, Vietnam as well as from most
countries in North America. 30
Very few foods in nature contain vitamin
D. The flesh of fatty fish (such as salmon, tuna,
and mackerel) and fish liver oils are among the
best sources. Small amounts of vitamin D are
found in beef liver, cheese, and egg yolks. Some
mushrooms provide vitamin D2 in variable
amounts.
Vitamin D aids the absorption of calcium
and hence is usually given together. In fact a
modest reduction in hip and other fractures can
be seen when low dose vitamin D (about 10 mcg
daily) was given with a calcium supplement as
compare to vitamin D given alone irrespective
of dose. However, there is a controversial risk
of nephrolithiasis with calcium / vitamin D
supplements. Meta-analyses reported an increased
risk of renal stones with the combination of
vitamin D and calcium though not for vitamin D
supplementation itself. 31 There is also a concern
that excessive calcium supplementation may
increase myocardial infarction risk. This risk
has not been seen with dietary calcium, only
with supplements. 32 Hence vitamin D and calcium
supplements should be used as an adjunct to a
balance healthy lifestyle of diet and exercise. As
recommended by the Osteoporosis Australia, a
supplement of no more than 500-600mg of Calcium
per day should be adequate. 18 Aim for a minimum
of 1000 mg calcium per day by diet to maintain
bone density. This is of course if secondary causes
of osteopenia/ osteoporosis have been ruled out.
To treat or not to treat
Whether pharmacological treatment is deemed
necessary if osteopenia (without fracture) is detected
is still under heated debate. 33 While the most effective
anti-resorptive treatment today have a NNT (Numbers
needed to treat) value of around 13-15 for spine fracture
prevention, the NNT in osteopenia patients are 8-10
times higher. One important fact is that most patients
with osteopenia are younger. 32
Studies on bisphosphonates, have also noted that
clinical fractures were only significantly reduced in
patients with T-scores < −2.5 (osteoporosis range).
However the controversy is that morphometric fractures
have in the same study been shown to be reduced even
in patients with a T-score > −2.5. 34
Health care resources and health economics also
plays a role in this debate. One study found that at 50
years, only calcium and vitamin D was cost-effective
economically, whereas at 70 years, bisphosphonates and
raloxifene were cost-effective. 3
Hence most guidelines for osteopenic patients
therefore primarily focus on lifestyle changes ,
nutritional improvements, calcium and vitamin D
supplementation , exercise regimens as primary
interventions. Pharmacological treatment depends on
the outcome of a person’s fracture risk assessment.
There are various tools which are widely available
for the family doctor to help with this decision making.
The most widely available is the online FRAX®
tool which uses a range of 12 risk factors to predict
a person's risk of fracture because of weak bones.
This self-assessment tool gives a 10-year probability
of a fracture in the spine, hip, shoulder or wrist for
people aged between 40 and 90. It integrates the risks
associated with clinical risk factors as well as bone
mineral density (BMD) at the femoral neck. If the bone
mineral density is unavailable then the Fracture risk
calculator developed by the Garvan Institute of Medical
research can be used.
So should family doctors screen for osteopenia?
There are many considerations but ultimately this
is a very person specific decision. A patient agreed
management plan is the best option to optimise the
health of the person in front of us.
Kathy KL Tsim, MBChB (Glasgow), FHKCFP, FRACGP, FHKAM (Family
Medicine)
Resident Specialist,
Tseung Kwan O (Po Ning Road) General Out-patient Clinic
Correspondence to:Dr Kathy KL Tsim, Tseung Kwan O (Po Ning Road)
General
Out-patient Clinic, G/F, 28 Po Ning Road, Tseung Kwan O,
Hong Kong SAR.
E-mail: kathymo@hotmail.com
References:
- Royal Osteoporosis Society. Osteopenia. 2020. Available from: https://
theros.org.uk/information-and-support/understanding-osteoporosis/
osteopenia/ [accessed 2019 Dec 22]
- Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis
and systematic review. BMC Public Health. 2016 Oct 3;16(1):1039.
- International Osteoporosis Foundation. Facts and statistics. 2020. Available
from: https://www.iofbonehealth.org/facts-statistics#category-26 [accessed
2019 Dec 22]
- Mithal A, Bansal B, Kyer CS, et al. The Asia-Pacifc regional auditepidemiology,
costs & burden of osteoporosis in India 2013: a report of
International Osteoporosis Foundation. Indian Journal of Endocrinology
and Metabolism. 2014;18(4):449-454.
- Hassan EB, Duque G. Osteosarcopenia: A new geriatric syndrome.
Australian Family Physician. 2017 Nov;46(11):849-853.
- Sun Q, Zheng Y, Chen K, et al. Osteopenia is associated with glycemic
levels and blood pressure in Chinese postmenopausal women: a crosssectional study.
Clin Exp Med. 2017 Feb;17(1):85-91. doi: 10.1007/s10238-
015-0397-7. [Epub 2015 Nov 29.]
- Liu M, Lu Y, Cheng X, et al. Relationship between abnormal glucose
metabolism and osteoporosis in Han Chinese men over the age of 50 years. Clin
Interv Aging. 2019;14:445-451. doi: 10.2147/CIA.S164021. [Epub 2019 Feb 25.]
- Guja C, Guja L, Miulescu RD. Effect of type 2 diabetes medications on
fracture risk. Ann Transl Med. 2019;7(20):580. doi:10.21037/atm.2019.09.51.
- Löff ler MT, Sollmann N, Mei K, et al. X-ray-based quantitative
osteoporosis imaging at the spine. Osteoporos Int. 2020 Feb;31(2):233-250.
- Xu XM, Li N, Li K, et al. Discordance in diagnosis of osteoporosis by
quantitative computed tomography and dual-energy X-ray absorptiometry
in Chinese elderly men. J Orthop Translat. 2018 Dec 21;18:59-64.
- Maghraoui AEl. Interpreting a DXA scan in clinical practice. IntechOpen. 2012.
- WHO Scientific group on the assessment of osteoprosis at the primary
health care level, World Health Organization (WHO). Summary Meeting
Report. 2004 May 5-7.
- WHO Scientific group on the assessment of osteoprosis at the primary
health care level, World Health Organization (WHO). Summary Meeting
Report. 2004 May 5-7.
- Chen JH, Chen YC, et al. Predicting the risk of osteopenia for women aged
40-55 years. J Formos Med Assoc. 2017 Nov;116(11):888-896. doi: 10.1016/
j.jfma.2017.01.003. [Epub 2017 Feb 16.]
- Mersebach, H, Johansson, J, Rasmussen å, et al. Osteopenia: a common
aspect of fabry disease. Predictors of bone mineral density. Genet Med.
2007;9:812-818. doi:10.1097/GIM.0b013e31815cb197.
- Nguyen TV, Livshits G, Center JR, et al. Genetic determination of bone
mineral density: evidence for a major gene. J Clin Endocrinol Metab. 2003
Aug;88(8):3614-3620. Available from: https://doi.org/10.1210/jc.2002-030026
- Karaguzel G, Holick MF. Diagnosis and treatment of osteopenia. Rev Endocr
Metab Disord. 2010 Dec;11(4):237-251. doi: 10.1007/s11154-010-9154-0.
- Osteoporsis Australia. Osteopenia. Consumer factsheet. 1st Edition 2/15.
- Zamoscinska M, Faber IR, Büsch D. Do older adults with reduced bone mineral
density benefit from strength training? A critically appraised topic. J Sport
Rehabil. 2019 Dec 12:1-8. doi: 10.1123/jsr.2019-0170. [Epub ahead of print]
- Miller KE. Impact of intense exercise on early osteopenia in women. Am
Fam Physician. 2005 Feb 15;71(4):796-798.
- Osteoporosis Australia Medical & Scientific Advisory Committee. Exercise
and bone density. Available from: https://www.osteoporosis.org.au/exercise.
- National Osteoporosis Foundation. Weight bearing. Available from: https://
www.nof.org/preventing-fractures/exercise-to-stay-healthy/weight-bearing/
[accessed 2020 Apr 7]
- National Institutes of Health, Office of Dietary Supplements (ODS).
Calcium: Fact sheet for health professionals. 2019 Oct 16.
- Student Health Service, Department of Health, The Government of the
Hong Kong Special Administrative Region of the People’s Republic of
China. Facts about Calcium 2018.) [accessed 2019 Dec 23]
- International Osteoporosis Foundation. The Asian Audit: Epidemiology,
costs and burden of osteoporosis in Asia 2009. Available from: www.
iofbonehealth.org.
- Zhao A, Xue Y, Zhang Y, et al. Nutrition concerns of insufficient and
excessive intake of dietary minerals in lactating women: a cross-sectional
survey in three cities of China. PLoS One. 2016;11(1):e0146483. doi:10.1371/
journal.pone.0146483. [Epub 2016 Jan 5.]
- Huang F, Wang Z, Zhang J, et al. Dietary calcium intake and food sources
among Chinese adults in CNTCS. PLoS One. 2018;13(10):e0205045.
doi:10.1371/journal.pone.0205045. [Epub 2018 Oct 1.]
- Wang EW, Pang MY, et al. Vitamin D status and cardiometabolic risk
factors in young adults in Hong Kong: associations and implications. Asia
Pac J Clin Nutr. 2018;27(1):231-237. doi: 10.6133/apjcn.022017.08.
- Family Health services. Patient information - Vitamin D. July 2016
- Xu C , Perera RAPM , Chan YH , et al. Determinants of serum
25-hydroxyvitamin D in Hong Kong. British Journal of Nutrition.
[Online] Cambridge University Press; 2015;114(1):144-151. Available from:
doi:10.1017/S0007114515001683.
- Abrahamsen B. The calcium and vitamin D controversy. Ther Adv
Musculoskelet Dis. 2017;9(5):107-114. doi:10.1177/1759720X16685547.
- Ewald D. Osteoporosis-Prevention and detection in general practice. Aust
Fam Physician. 2012 Mar;41(3):104-108.
- Zhang J, Morgan SL, Saag KG. Osteopenia: debates and dilemmas. Curr
Rheumatol Rep. 2013 Dec;15(12):384. doi: 10.1007/s11926-013-0384-5.
- Eriksen, E.F. Treatment of osteopenia. Rev Endocr Metab Disord. 2012
Sep;13(3):209-223. doi: 10.1007/s11154-011-9187-z.
- Lamy O, Krieg MA. Effects of different treatments for osteoporosis on
prevention of fractures: toward and individualized and economic approach.
Praxis (Bern 1994). 2004 Mar 10;93(11):399-405.
|